Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | BRD4 | O60885 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.45 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.45 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
| ▸ | XDH | P47989 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19911399 | 0.87 | FGFR1 (0.60) | MAPTALDH1A1HPGDPKMSMN1; SMN2 | |
| SCHEMBL211698 | 0.80 | L3MBTL1 (0.61) | MAPTALDH1A1HPGDPKMSMN1; SMN2 | |
| SCHEMBL28299485 | 0.80 | ALDH1A1 (0.60) | MAPTALDH1A1HPGDPKMSMN1; SMN2 | |
| SCHEMBL594361 | 0.80 | ALDH1A1 (0.60) | MAPTALDH1A1HPGDPKMSMN1; SMN2 | |
| SCHEMBL11050724 | 0.79 | ALDH1A1 (0.58) | MAPTALDH1A1HPGDPKMSMN1; SMN2 | |
| SCHEMBL19911367 | 0.78 | ALDH1A1 (0.57) | MAPTALDH1A1HPGDPKMSMN1; SMN2 | |
| SCHEMBL19911380 | 0.76 | ALDH1A1 (0.56) | MAPTALDH1A1HPGDPKMSMN1; SMN2 | |
| SCHEMBL12732375 | 0.76 | ALDH1A1 (0.56) | MAPTALDH1A1HPGDPKMSMN1; SMN2 | |
| SCHEMBL22449397 | 0.76 | ALDH1A1 (0.56) | MAPTALDH1A1HPGDPKMSMN1; SMN2 | |
| SCHEMBL31304613 | 0.76 | ALDH1A1 (0.56) | MAPTALDH1A1HPGDPKMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | BPTF, BRD4, KCNN2 | MAPT 1283/4885ALDH1A1 3497/4885HPGD 2179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.